Lymphotoxin αβ2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5358-5366

  Xu, Guilian ^a,d   Liu, Dong ^a   Fan, Yijun ^a   Yang, Xi ^a   Korner, Heinrich ^b   Fu, Yang Xin ^c   Uzonna, Jude E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF CHICAGO   (United States)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 12; LIGAND; LYMPHOTOXIN ALPHA BETA; LYMPHOTOXIN ALPHA BETA 2; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RESISTANCE; INFLAMMATION; INTERFERON PRODUCTION; KNOCKOUT MOUSE; LEISHMANIA MAJOR; LEISHMANIASIS; LIGHT CHAIN; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN DEFECT; SPLEEN CELL; WILD TYPE;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; FEMALE; IMMUNITY, INNATE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIATION CHIMERA;

EID: 47249133986     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5358     Document Type: Article

References (63)

1. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501.
2. Bodmer, J. L., P. Schneider, and J. Tschopp. 2002. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27: 19-26.
3. Benedict, C. A., T. A. Banks, and C. F. Ware. 2003. Death and survival: viral regulation of TNF signaling pathways. Curr. Opin. Immunol. 15: 59-65.
4. Ware, C. F. 2003. The TNF superfamily. Cytokine Growth Factor Rev. 14: 181-184.
5. Ware, C. F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol. 23: 787-819.
6. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145: 4306-4310.
7. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumour necrosis factor (TNF-α) in leishmaniasis, II: TNF-α-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71: 556-559.
8. Kanaly, S. T., M. Nashleanas, B. Hondowicz, and P. Scott. 1999. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J. Immunol. 163: 3883-3889.
9. Wilhelm, P., U. Ritter, S. Labbow, N. Donhauser, M. Rollinghoff, C. Bogdan, and H. Korner. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166: 4012-4019.
10. Ritter, U., J. Mattner, J. S. Rocha, C. Bogdan, and H. Korner. 2004. The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes Infect. 6: 559-565.
11. Murphy, K. M., C. A. Nelson, and J. R. Sedy. 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6: 671-681.
12. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8: 21-30.
13. Wilhelm, P., D. S. Riminton, U. Ritter, F. A. Lemckert, C. Scheidig, R. Hoek, J. D. Sedgwick, and H. Korner. 2002. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs. Eur. J. Immunol. 32: 1993-2003.
14. Tumanov, A. V., S. I. Grivennikov, A. N. Shakhov, S. A. Rybtsov, E. P. Koroleva, J. Takeda, S. A. Nedospasov, and D. V. Kuprash. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195: 106-116.
15. Tumanov, A. V., D. V. Kuprash, and S. A. Nedospasov. 2003. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev. 14: 275-288.
16. Gommerman, J. L., and J. L. Browning. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3: 642-655.
17. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6: 491-500.
18. Scheu, S., J. Alferink, T. Potzel, W. Barchet, U. Kalinke, and K. Pfeffer. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J. Exp. Med. 195: 1613-1624.
19. Schluter, D., L. Y. Kwok, S. Lutjen, S. Soltek, S. Hoffmann, H. Korner, and M. Deckert. 2003. Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170: 6172-6182.
20. de Kossodo, S., G. E. Grau, J. A. Louis, and I. Muller. 1994. Tumor necrosis factor α (TNF-α) and TNF-β and their receptors in experimental cutaneous leishmaniasis. Infect. Immun. 62: 1414-1420.
21. Roach, D. R., H. Briscoe, B. Saunders, M. P. France, S. Riminton, and W. J. Britton. 2001. Secreted lymphotoxin-α is essential for the control of an intracellular bacterial infection. J. Exp. Med. 193: 239-246.
22. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151-177.
23. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2: 845-858.
24. Scott, P., and J. P. Farrell. 1998. Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chem. Immunol. 70: 60-80.
25. Ngo, V. N., H. Korner, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189: 403-412.
26. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110.
27. + Th1 cell development and resistance to Leishmania major. J. Immunol. 170: 1995-2003.
28. Speirs, K., J. Caamano, M. H. Goldschmidt, C. A. Hunter, and P. Scott. 2002. NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 168: 4406-4413.
29. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141: 2407-2412.
30. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7: 545-555.
31. Liew, F. Y. 1994. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol. Lett. 43: 95-98.
32. Fonseca, S. G., P. R. Romao, F. Figueiredo, R. H. Morais, H. C. Lima, S. H. Ferreira, and F. Q. Cunha. 2003. TNF-α mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis. Eur. J. Immunol. 33: 2297-2306.
33. Scott, P. 1993. IL-12: Initiation cytokine for cell-mediated immunity. Science 260: 496-497.
34. + T-cell subsets in vivo. Immunol. Rev. 123: 189-207.
35. + subsets in leishmaniasis. J. Cell. Biochem. 53: 323-328.
36. Sacks, D. L., P. A. Scott, R. Asofsky, and F. A. Sher. 1984. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 132: 2072-2077.
37. Hoerauf, A., W. Solbach, M. Lohoff, and M. Rollinghoff. 1994. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int. Immunol. 6: 1117-1124.
38. Buxbaum, L. U., and P. Scott. 2005. Interleukin 10- and Fcγ receptor-deficient mice resolve Leishmania mexicana lesions. Infect. Immun. 73: 2101-2108.
39. Miles, S. A., S. M. Conrad, R. G. Alves, S. M. Jeronimo, and D. M. Mosser. 2005. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201: 747-754.
40. Woelbing, F., S. L. Kostka, K. Moelle, Y. Belkaid, C. Sunderkoetter, S. Verbeek, A. Waisman, A. P. Nigg, J. Knop, M. C. Udey, and E. von Stebut. 2006. Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. J. Exp. Med. 203: 177-188.
41. Konecny, P., A. J. Stagg, H. Jebbari, N. English, R. N. Davidson, and S. C. Knight. 1999. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur. J. Immunol. 29: 1803-1811.
42. von Stebut, E., Y. Belkaid, B. V. Nguyen, M. Cushing, D. L. Sacks, and M. C. Udey. 2000. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis. Eur. J. Immunol. 30: 3498-3506.
43. Gorak, P. M., C. R. Engwerda, and P. M. Kaye. 1998. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28: 687-695.
44. Schneider, K., K. G. Potter, and C. F. Ware. 2004. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol. Rev. 202: 49-66.
45. Berger, D. P., D. Naniche, M. T. Crowley, P. A. Koni, R. A. Flavell, and M. B. Oldstone. 1999. Lymphotoxin-β-deficient mice show defective antiviral immunity. Virology 260: 136-147.
46. Morel, Y., A. Truneh, R. W. Sweet, D. Olive, and R. T. Costello. 2001. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167: 2479-2486.
47. Ehlers, S., C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer. 2003. The lymphotoxin β receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J. Immunol. 170: 5210-5218.
48. Lucas, R., F. Tacchini-Cottier, R. Guler, D. Vesin, S. Jemelin, M. L. Olleros, G. Marchal, J. L. Browning, P. Vassalli, and I. Garcia. 1999. A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection. Eur. J. Immunol. 29: 4002-4010.
49. Puglielli, M. T., J. L. Browning, A. W. Brewer, R. D. Schreiber, W. J. Shieh, J. D. Altman, M. B. Oldstone, S. R. Zaki, and R. Ahmed. 1999. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway. Nat. Med. 5: 1370-1374.
50. Lin, X., X. Ma, M. Rodriguez, X. Feng, L. Zoecklein, Y. X. Fu, and R. P. Roos. 2003. Membrane lymphotoxin is required for resistance to Theiler's virus infection. Int. Immunol. 15: 955-962.
51. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377.
52. Laskay, T., I. Wittmann, A. Diefenbach, M. Rollinghoff, and W. Solbach. 1997. In vivo blocking of L-selectin rescues BALB/c mice from fatal Leishmania major infection. Immunol. Lett. 57: 89-91.
53. Uzonna, J. E., R. S. Kaushik, J. R. Gordon, and H. Tabel. 1998. Experimental murine Trypanosoma congolense infections: I. Administration of anti-IFN-γ antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. J. Immunol. 161: 5507-5515.
54. Shi, M., W. Pan, and H. Tabel. 2003. Experimental African trypanosomiasis: IFN-γ mediates early mortality. Eur. J. Immunol. 33: 108-118.
55. Wu, Q., Y. Wang, J. Wang, E. O. Hedgeman, J. L. Browning, and Y. X. Fu. 1999. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190: 629-638.
56. Abe, K., F. O. Yarovinsky, T. Murakami, A. N. Shakhov, A. V. Tumanov, D. Ito, L. N. Drutskaya, K. Pfeffer, D. V. Kuprash, K. L. Komschlies, and S. A. Nedospasov. 2003. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo. Blood 101: 1477-1483.
57. Browning, J. L., and L. E. French. 2002. Visualization of lymphotoxin-β and lymphotoxin-β receptor expression in mouse embryos. J. Immunol. 168: 5079-5087.
58. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, and D. R. Green. 2002. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17: 525-535.
59. Wang, Y. G., K. D. Kim, J. Wang, P. Yu, and Y. X. Fu. 2005. Stimulating lymphotoxin β receptor on the dendritic cells is critical for their homeostasis and expansion. J. Immunol. 175: 6997-7002.
60. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752.
61. Summers-Deluca, L. E., D. D. McCarthy, B. Cosovic, L. A. Ward, C. C. Lo, S. Scheu, K. Pfeffer, and J. L. Gommerman. 2007. Expression of lymphotoxin-αβ on antigen-specific T cells is required for DC function. J. Exp. Med. 204: 1071-1081.
62. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147.
63. Groux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M. G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162: 1723-1729.